Molding therapy of positional plagiocephaly: subjective outcome and quality of life

Bastiaan Govaert1, Alice Michels, Carlo Colla

  • 1Department of Plastic, Reconstructive and Hand Surgery, University Hospital Maastricht, Maastricht, The Netherlands. basgovaert@hotmail.com

Insights

Molding helmet therapy (MHT) for positional plagiocephaly in children showed no adverse effects on quality of life (QOL). Parents reported significant satisfaction with head shape improvements after MHT.

Area of Science:

  • Pediatric Plastic Surgery
  • Craniofacial Abnormalities
  • Quality of Life Research

Background:

  • Positional plagiocephaly is a common condition in infants.
  • Molding helmet therapy (MHT) is a primary treatment for moderate to severe cases.
  • Evaluating treatment outcomes, including quality of life and parental satisfaction, is crucial.

Purpose of the Study:

  • To assess the quality of life (QOL) in children treated with MHT for positional plagiocephaly.
  • To evaluate parental satisfaction with head shape outcomes post-MHT.
  • To compare QOL in treated children with a healthy control group.

Main Methods:

  • Retrospective chart review of 166 children treated at a craniofacial clinic.
  • Administration of the TAPQOL questionnaire to assess QOL.
  • Parental satisfaction questionnaires regarding head shape before and after MHT.

Main Results:

  • No significant difference in QOL scores between children treated with MHT and a healthy control group.
  • Parents reported a significant increase in satisfaction with head shape after MHT (average rating from 3.6 to 7.5).
  • 96% of parents would recommend or repeat MHT, citing positive results and therapy experience.

Conclusions:

  • MHT for severe positional plagiocephaly does not negatively impact long-term QOL in children.
  • MHT effectively improves head shape and parental satisfaction.
  • The therapy is generally well-tolerated and yields satisfactory outcomes.